In this work, we reported that PSII could inhibit the viability and motility of HNSCC cell lines, cancer stem cells, and primary cultured fibroblasts from the tissue through the mitochondrial pathway by targeting NOS3 as well as inducing autophagy and apoptosis through a series of changes of metabolites in vivo and in vitro. The gene discussed is NOS3; the disease is cancer.